相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease
A. Buisson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Long-term infliximab maintenance therapy for ulcerative colitis: The ACT-1 and-2 extension studies
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2012)
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
Ivan Guerra et al.
JOURNAL OF CROHNS & COLITIS (2012)
Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: The Mayo Clinic experience, 1998 to 2010
Eugenia Shmidt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Paradoxical inflammation induced by anti-TNF agents in patients with IBD
Isabelle Cleynen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Craig Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Analysis of IL12B Gene Variants in Inflammatory Bowel Disease
Juergen Glas et al.
PLOS ONE (2012)
Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature
G. Cullen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect
Marisa Iborra et al.
JOURNAL OF CROHNS & COLITIS (2011)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Carl A. Anderson et al.
NATURE GENETICS (2011)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
Paola Di Meglio et al.
PLOS ONE (2011)
CEACAM6 Gene Variants in Inflammatory Bowel Disease
Juergen Glas et al.
PLOS ONE (2011)
Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q
Svetlana Pidasheva et al.
PLOS ONE (2011)
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+and CD8+human T-cell functional responses
Ritu Sarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti-Tumor Necrosis Factor Therapy
Jean-Francois Rahier et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Strong Overexpression of CXCR3 Axis Components in Childhood Inflammatory Bowel Disease
Sebastian Schroepf et al.
INFLAMMATORY BOWEL DISEASES (2010)
A Naturally Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human Th17 Cells
Raymond Y. Yu et al.
JOURNAL OF IMMUNOLOGY (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants
Juergen Glas et al.
PLOS ONE (2010)
Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease
Juerge N. Glas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register
M. J. Harrison et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Cytokine imbalance with increased production of interferon-α in psoriasiform eruptions associated with antitumour necrosis factor-α treatments
J. Seneschal et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
The role of the novel Th17 cytokine IL-26 in intestinal inflammation
J. Dambacher et al.
GUT (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
Severe Legionella pneumophila Pneumonia Following Infliximab Therapy in a Patient with Crohn's Disease
Florian Beigel et al.
INFLAMMATORY BOWEL DISEASES (2009)
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Justin M. Ko et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
Kerstin Wolk et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21
Xue-Jun Zhang et al.
NATURE GENETICS (2009)
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair et al.
NATURE GENETICS (2009)
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Florian Beigel et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Linking genetic susceptibility to Crohn's disease with Th17 cell function:: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status
Silke Schmechel et al.
INFLAMMATORY BOWEL DISEASES (2008)
Role of the novel th17 cytokine IL-17F in inflammatory bowel disease (IBD):: Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.Hisl6lArg polymorphism in IBD
Julia Seiderer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Induction of IL-17+ T cell trafficking and development by IFN-γ:: Mechanism and pathological relevance in psoriasis
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci
Ying Liu et al.
PLOS GENETICS (2008)
Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions
Jan Hendrik Niess et al.
JOURNAL OF IMMUNOLOGY (2008)
rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants
Juergen Glas et al.
PLOS ONE (2007)
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists
H-H. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions
Gillian C. de Gannes et al.
ARCHIVES OF DERMATOLOGY (2007)
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
Michele Cargill et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes:: a potential role in psoriasis
Kerstin Wolk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study
L Naldi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
K Boniface et al.
JOURNAL OF IMMUNOLOGY (2005)
Cross-regulation of TNF and IFN-α in autoimmune diseases
AK Palucka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Anti-interleukin-12 antibody for active Crohn's disease
PJ Mannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities
BJ Nickoloff et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Plasmacytoid dendritic cells:: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases
A Wollenberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C
AMR Downs et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2000)
分享论文
